Parkinson progression reduced by mild hyperbaric oxygen therapy

Mild or lower pressure hyperbaric oxygen therapy (aka m-HBOT) was able to demonstrate a marked reduction in Parkinson’s Disease (PD) symptoms in just 11 weeks!

PD is a common progressive neurodegenerative disease, of which the main neuropathological hallmark is dopaminergic neuronal loss (degeneration or loss of dopamine-producing neuronal cells). When dopamine-producing neurons die, motor functioning is affected and symptoms such as tremors, slowness, stiffness, and balance problems occur.

In this 11 week study, m-HBOT at 1.3 ATA (3 hours per day, 3 times per week) was able to protect the dopaminergic neurons from further loss and degeneration. More importantly, researchers observed positive effects in motor function <view study>